These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 25370677

  • 1. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
    Rodriguez M, Rogers DW.
    Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
    [Abstract] [Full Text] [Related]

  • 2. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
    Tedgren AC, Hedman A, Grindborg JE, Carlsson GA.
    Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
    [Abstract] [Full Text] [Related]

  • 3. On determining dose rate constants spectroscopically.
    Rodriguez M, Rogers DW.
    Med Phys; 2013 Jan; 40(1):011713. PubMed ID: 23298083
    [Abstract] [Full Text] [Related]

  • 4. Determination of the intrinsic energy dependence of LiF:Mg,Ti thermoluminescent dosimeters for 125I and 103Pd brachytherapy sources relative to 60Co.
    Reed JL, Rasmussen BE, Davis SD, Micka JA, Culberson WS, DeWerd LA.
    Med Phys; 2014 Dec; 41(12):122103. PubMed ID: 25471976
    [Abstract] [Full Text] [Related]

  • 5. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P, Molloy JA, Rivard MJ.
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [Abstract] [Full Text] [Related]

  • 6. Determination of absorbed dose to water around a clinical HDR (192)Ir source using LiF:Mg,Ti TLDs demonstrates an LET dependence of detector response.
    Carlsson Tedgren A, Elia R, Hedtjarn H, Olsson S, Alm Carlsson G.
    Med Phys; 2012 Feb; 39(2):1133-40. PubMed ID: 22320824
    [Abstract] [Full Text] [Related]

  • 7. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
    Lucas PA, Aubineau-Lanièce I, Lourenço V, Vermesse D, Cutarella D.
    Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
    [Abstract] [Full Text] [Related]

  • 8. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
    Chen Z, Bongiorni P, Nath R.
    Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
    [Abstract] [Full Text] [Related]

  • 9. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G, Papagiannis P, Sakelliou L, Karaiskos P, Sandilos P, Przykutta A, Baltas D.
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [Abstract] [Full Text] [Related]

  • 10. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
    Patel NS, Chiu-Tsao ST, Williamson JF, Fan P, Duckworth T, Shasha D, Harrison LB.
    Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
    [Abstract] [Full Text] [Related]

  • 11. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A, Pantelis E, Papagiannis P, Baltas D.
    Brachytherapy; 2014 Aug; 13(6):618-26. PubMed ID: 25108795
    [Abstract] [Full Text] [Related]

  • 12. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM, Rogers DW.
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [Abstract] [Full Text] [Related]

  • 13. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J, Lia Z, Williamson JF.
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [Abstract] [Full Text] [Related]

  • 14. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
    Chen ZJ, Bongiorni P, Nath R.
    Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
    [Abstract] [Full Text] [Related]

  • 15. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, Mitch MG, Nath R, Williamson JF.
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [Abstract] [Full Text] [Related]

  • 16. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM, Davis SD, Micka JA, DeWerd LA.
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [Abstract] [Full Text] [Related]

  • 17. Experimental and Monte Carlo dosimetric characterization of a 1 cm (103)Pd brachytherapy source.
    Reed JL, Rivard MJ, Micka JA, Culberson WS, DeWerd LA.
    Brachytherapy; 2014 Apr; 13(6):657-67. PubMed ID: 24880585
    [Abstract] [Full Text] [Related]

  • 18. Influence of phantom materials on the energy dependence of LiF:Mg,Ti thermoluminescent dosimeters exposed to 20-300 kV narrow x-ray spectra, 137Cs and 60Co photons.
    Massillon-J L G, Cabrera-Santiago A, Minniti R, O'Brien M, Soares CG.
    Phys Med Biol; 2014 Aug 07; 59(15):4149-66. PubMed ID: 25004055
    [Abstract] [Full Text] [Related]

  • 19. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M, Martinov M, Thomson RM.
    Med Phys; 2014 Mar 07; 41(3):031706. PubMed ID: 24593710
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.